Article info
PDFEvidence synthesis
General medicine
Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management
- Correspondence to Dr Vicki Osborne, Drug Safety Research Unit, Southampton SO31 1AA, UK; vicki.osborne{at}dsru.org
Citation
Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management
Publication history
- Accepted February 13, 2020
- First published February 24, 2020.
Online issue publication
November 23, 2020
Article Versions
- Previous version (24 February 2020).
- Previous version (5 March 2020).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.